Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Golden Dragon Holding Co. (CPMD : OTC)

• Company Description    CannaPharmaRX, Inc. is a pharmaceutical company. The company is engaged in cannabinoid discovery, science, research & development. Cannapharmarx Inc., formerly known as Golden Dragon Holding Co., is based in Carneys Point, New Jersey. Number of Employees: 26

• Price / Volume Information    Yesterday's Closing Price: $0.00 Daily Weekly Monthly 20 Day Moving Average: 17,947 shares Shares Outstanding: 706.82 (millions) Market Capitalization: $1.41 (millions) Beta: 2.36 52 Week High: $0.01 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.00% -0.66% 12 Week -4.76% -10.18% Year To Date -61.54% -66.06%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 4439 TOWNSHIP RD 304 - MOUNTAIN VIEW COUNTY,A0 T0M0R0 CAN ph: 949-652-6838 fax: 720-875-1905 info@cannapharmarx.com http://www.cannapharmarx.com

• General Corporate Information    Officers Constantine Nkafu - Chief Executive Officer Oliver Foeste - Chief Financial Officer Anthony Panek - Director Dominic Colvin - Director Elliot Zemel - Director Peer Information Golden Dragon Holding Co. (GSAC) Golden Dragon Holding Co. (CASIF) Golden Dragon Holding Co. (ALCD.) Golden Dragon Holding Co. (OMNN) Golden Dragon Holding Co. (CGPI.) Golden Dragon Holding Co. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 13765D109 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/13/26 Share - Related Items Shares Outstanding: 706.82 Most Recent Split Date: 11.00 (0.10:1) Beta: 2.36 Market Capitalization: $1.41 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.83 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: 18.97% vs. Previous Quarter: -55.98% ROE 09/30/26 - - 06/30/26 - - 03/31/26 - - ROA 09/30/26 - - 06/30/26 - -141.01 03/31/26 - -118.00 Current Ratio 09/30/26 - - 06/30/26 - 0.04 03/31/26 - 0.03 Quick Ratio 09/30/26 - - 06/30/26 - 0.00 03/31/26 - 0.00 Operating Margin 09/30/26 - - 06/30/26 - -666.22 03/31/26 - -653.96 Net Margin 09/30/26 - - 06/30/26 - -666.22 03/31/26 - -654.02 Pre-Tax Margin 09/30/26 - - 06/30/26 - -666.16 03/31/26 - -653.90 Book Value 09/30/26 - - 06/30/26 - -0.04 03/31/26 - -0.05 Inventory Turnover 09/30/26 - - 06/30/26 - 3.06 03/31/26 - 3.71 Debt-to-Equity 09/30/26 - - 06/30/26 - - 03/31/26 - - Debt-to-Capital 09/30/26 - - 06/30/26 - - 03/31/26 - -

Powered by Zacks Investment Research ©